Oral Presentation (O06) | BioBehçet’s: Optimal utilisation of biologic drugs in Behçet’s Disease: a randomised controlled trial of infliximab vs alpha interferon, with genotyping and metabolomic profiling, towards a stratified medicines approach to treatment

july, 2022

thu07jul17:1017:20Oral Presentation (O06) | BioBehçet’s: Optimal utilisation of biologic drugs in Behçet’s Disease: a randomised controlled trial of infliximab vs alpha interferon, with genotyping and metabolomic profiling, towards a stratified medicines approach to treatmentRobert Moots17:10 - 17:20

Virtual Event Details

Event has already taken place!

Time

(Thursday) 17:10 - 17:20

Leave a Reply

X
Skip to toolbar